Ali Akdoğan

6PUBLICATIONS
34CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritisPredictive and prognostic markersMolecular targetsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 31, 2026
Efficacy and safety of leflunomide with tumor necrosis factor inhibitors in psoriatic arthritis: a retrospective analysis.

|Jul 21, 2025
Janus kinase inhibitors in localized scleroderma: a systematic literature review.

Seher Şener, Yusuf Ziya Şener, Ezgi Deniz Batu

|Jul 25, 2024
Prognostic factors for interstitial lung disease progression in rheumatoid arthritis: May methotrexate protect against progression?

M Ekici, Y Baytar, A Akdoğan

|Dec 06, 2023
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates.

Güllü Sandal Uzun, Arzu Taghiyeva, İbrahim Y Çakır

|Jun 09, 2023
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry.

Emine Duran, Zeynep Ozge Ozturk, Emre Bilgin

|Dec 12, 2022
Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone.

M Kiracı, E Bilgin, E Duran

Pageof 1

Frequent Collaborators

5 joint publications

Umut Kalyoncu

4 joint publications

Sedat Kiraz

4 joint publications

Emre Bilgin

4 joint publications

Ali Ihsan Ertenli